PLEKHO2

Model summary

A human cytoplasmic scaffold that uses a pleckstrin homology module to dock onto phosphoinositide-rich membrane sites and assemble multiprotein complexes that tune survival pathways in myeloid lineages. By cycling between cytosol and membrane-proximal assemblies, it modulates apoptotic thresholds and interfaces with secretory pathways characteristic of neutrophil and monocyte biology, including trafficking through ficolin-1–rich granules and occasional extracellular exposure via regulated secretion.

Predicted Gene Ontology terms

1. 01

   I begin with the InterPro architecture.

   The N-terminus harbors IPR011993 (PH-like domain superfamily, residues 4–117), within which sits a canonical IPR001849 Pleckstrin homology (PH) domain spanning residues 18–121. This tandem of a PH core embedded in a broader PH-like scaffold is followed by a long family-specific region annotated as IPR043448 (Pleckstrin homology domain-containing family O member 1/2, residues 1–490), which covers essentially the full length and signals a conserved, non-enzymatic module specialized for membrane- and signaling-associated interactions. PH domains create a basic, β-sandwich pocket that binds phosphoinositides and often recruits protein partners; this architecture causes avid membrane association and multivalent protein binding rather than catalysis. Consequently, the primary molecular function is mediated through GO:0005515 protein binding, with lipid-anchored scaffolding as the mechanistic basis.

2. 02

   From this scaffolded PH platform, I infer the biological role.

   PH-driven assemblies typically tune receptor and cytoskeletal pathways that govern survival and death decisions in hematopoietic lineages. The family-level signature (IPR043448) ties the protein to a cohort implicated in myeloid signaling. Such scaffolds can bias signaling thresholds that trigger or suppress programmed cell death. This causal chain—PH-mediated membrane recruitment and complex assembly leading to fate-control—aligns with the process formalized as GO:0033028 myeloid cell apoptotic process.

3. 03

   Cellular location follows from the same architecture and lineage context.

   PH-mediated membrane affinity and soluble scaffolding predict a cytosolic pool and peripheral membrane association, consistent with a cytoplasmic residency. In myeloid cells, secretory pathways and specialized granules store and release proteins; the presence of GO:0030141 secretory granule and GO:1904813 ficolin-1-rich granule lumen indicates trafficking through, or cargo within, ficolin-1–rich granules characteristic of neutrophil/monocyte lineages. Such granules can transiently expose their luminal cargo to the extracellular milieu; thus GO:0005576 extracellular region is explained by granule-mediated secretion or surface deposition during inflammatory responses. Together, these compartments situate the protein primarily in the cytoplasm with regulated access to secretory granules and occasional extracellular exposure.

4. 04

   Mechanistically, I hypothesize that the PH domain targets phosphoinositide-enriched membrane microdomains, where the protein nucleates complexes that modulate receptor signaling and cytoskeletal dynamics to tune apoptosis in myeloid cells.

   It likely cycles between cytosol and membrane-adjacent assemblies, and in myeloid lineages it traffics through ficolin-1-rich granules. Likely partners include phosphoinositide-metabolic enzymes and membrane adaptors that together set apoptotic thresholds and coordinate secretion.

5. 05

   To hypothesize interaction partners: the PH scaffold favors transient complexes with phosphoinositide kinases/phosphatases and membrane adaptors.

   Candidates include PI3K regulatory subunits and PTEN as lipid-node partners; small GTPases and actin regulators that couple signaling to morphology; and myeloid-specific granule proteins whose luminal pathways route through ficolin-1-rich compartments. These assemblies would causally connect membrane identity to apoptotic control and secretory trafficking in hematopoietic cells.